Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's Disease
Sponsor: University Medical Center Groningen
Summary
The goal of this clinical trial is to learn if FAPI-PET/CT and/or FDG-PET/CT scan is able to detect active fibroblast tissue and inflammation in patients with acute or chronic phase PD. * Does FAPI PET/CT scan or FDG PET/CT scan show any uptake of inflammatory tissue in patients with Peyronie's disease * Participants will undergo a FAPI PET/CT scan and FDG PET/CT scan after diagnosis of Peyronie's disease.
Official title: The Use of FAPI-PET/CT and FDG-PET/CT Scan in Acute and Chronic Phase Peyronie's Disease for Detection of Active Fibroblasts and Inflammation in the Penis - a Pilot Study
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2024-12-13
Completion Date
2027-09-15
Last Updated
2026-11-03
Healthy Volunteers
No
Conditions
Interventions
68Ga-FAPI (gallium-68-labeled fibroblast activation protein inhibitor)
1 dosage for PET/scan of 200 MBq
Locations (1)
St Antoniusziekenhuis
Nieuwegein, Utrecht, Netherlands